- Filed
- Mar 17, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 7, 2025 | 6.86M sh |
| Cash And Equivalents | Q3 2025 · Jan 31, 2025 | $16.38M |
| Cash And Equivalents | Q3 2025 · Apr 30, 2024 | $50.18M |
| Current Liabilities | Q3 2025 · Jan 31, 2025 | $1.19M |
| Current Liabilities | Q3 2025 · Apr 30, 2024 | $7.42M |
| Total Liabilities | Q3 2025 · Jan 31, 2025 | $3.58M |
| Total Liabilities | Q3 2025 · Apr 30, 2024 | $20.39M |
| Current Assets | Q3 2025 · Jan 31, 2025 | $16.96M |
| Current Assets | Q3 2025 · Apr 30, 2024 | $50.44M |
| Total Assets | Q3 2025 · Jan 31, 2025 | $43.83M |
| Total Assets | Q3 2025 · Apr 30, 2024 | $59.9M |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 8.61M sh |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 9.99M sh |
| Stock Repurchased | Q3 2025 · Jan 31, 2024 | $27.02M |
| Operating Cash Flow | Q3 2025 · Jan 31, 2024 | −$1.82M |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | $31.37M |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | $36.77M |
| Stockholders Equity | Q3 2025 · Jul 31, 2023 | $39.19M |
| Stockholders Equity | Q3 2025 · Apr 30, 2023 | $72.69M |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | −$0.65 |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | −$1.47 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | −$0.65 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | −$1.47 |
| Rd Expense | Q3 2025 · Jan 31, 2024 | $126.73K |
| Rd Expense | Q3 2025 · Jan 31, 2024 | $313.25K |
| Net Income | Q3 2025 · Jan 31, 2024 | −$619.54K |
| Net Income | Q3 2025 · Jan 31, 2024 | −$1.01M |
| Net Income | Q3 2025 · Oct 31, 2023 | $2.79M |
| Net Income | Q3 2025 · Jul 31, 2023 | −$3.18M |
| Operating Income | Q3 2025 · Jan 31, 2024 | −$1.87M |
| Operating Income | Q3 2025 · Jan 31, 2024 | −$5.35M |
| Revenue | Q3 2025 · Jan 31, 2024 | $0 |
| Revenue | Q3 2025 · Jan 31, 2024 | $0 |